Pharmacokinetics of Levofloxacin in Intensive Care Unit
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is 1. to describe levofloxacin pharmacokinetics in ICU patients
suffering from pneumonia with taking into account physio-pathological parameters. 2. to
verify clinical and bacteriological efficiency and to know if the peak/Minimum Inhibitory
Concentration (MIC) ratio > 5 and Area Under Curve (AUC) /Minimum Inhibitory
Concentration(MIC) ratio > 125. No therapeutic drug monitoring will be performed in this
study.